Viscosupplementation with Hyaluronic Acid in Hip Osteoarthritis (a review)

References

• Lawrence, R. C., Helmick, C. G., Arnett, F. C., Deyo, R. A., Felson, D. T., Giannini, E. H., Heyse, S. P., Hirsch, R., Hochberg, M. C., Hunder, G. G., Liang, M. H., Pillemer, S. R., Steen, V. D., and Wolfe, F. (1998). Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 41: 778–799
   PubMed Web of Science ®Google Scholar
• Altman, R., Alarcon, G., Appelrouth, D., Bloch, D., Borenstein, D., Brandt, K., Brown, C., Cooke, T. D., Daniel, W., Feldman, D., and. (1991). The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 34: 505–514
   Google Scholar
• Page, J. and Henry, D. (2000). Consumption of NSAIDs and the development of congestiveheart failure in elderly patients: an underrecognized public health problem. Arch.Intern.Med. 160: 777–784
   PubMed Web of Science ®Google Scholar
• Hochberg, M. C., Altman, R. D., Brandt, K. D., Clark, B. M., Dieppe, P. A., Griffin, M. R., Mos-kowitz, R. W., and Schnitzer, T. J. (1995). Guidelines for the medical management of osteoar-thritis. Part I. Osteoarthritis of the hip.American College of Rheumatology. Arthritis Rheum. 38: 1535–1540
   Google Scholar
• Psaty, B. M. and Furberg, C. D. (2005). COX-2 inhibitors--lessons in drug safety. N.Engl.J.Med.352: 1133–1135
   PubMed Web of Science ®Google Scholar
• Sturkenboom, M. C., Romano, F., Simon, G., Correa-Leite, M. L., Villa, M., Nicolosi, A., Bor-gnolo, G., Bianchi-Porro, G., and Mannino, S. (2002). The iatrogenic costs of NSAID therapy: a population study. Arthritis Rheum. 47: 132–140
   Google Scholar
• Flanagan, J., Casale, F. F., Thomas, T. L., and Desai, K. B. (1988). Intra-articular injection for pain relief in patients awaiting hip replacement. Ann.R.Coll.Surg.Engl. 70: 156–157
   PubMed Web of Science ®Google Scholar
• Plant, M. J., Borg, A. A., Dziedzic, K., Saklatvala, J., and Dawes, P. T. (1997). Radiographic pat-terns and response to corticosteroid hip injection. Ann.Rheum.Dis. 56: 476–480
   PubMed Web of Science ®Google Scholar
• Altman, R. D. (2000). Intra-articular sodium hyaluronate in osteoarthritis of the knee. Semin.Arthritis Rheum. 30: 11–18
   PubMed Web of Science ®Google Scholar
• Kolarz, G., Kotz, R., and Hochmayer, I. (2003). Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin. Arthritis Rheum. 32: 310–319
   PubMed Web of Science ®Google Scholar
• Raynauld, J. P., Torrance, G. W., Band, P. A., Goldsmith, C. H., Tugwell, P., Walker, V, Schultz, M., and Bellamy, N. (2002). A prospective, randomized, pragmatic, health outcomes trial evaluat-ing the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoar-thritis (Part 1 of 2): clinical results. Osteoarthritis.Cartilage. 10: 506–517
   PubMed Web of Science ®Google Scholar
• Tamir, E., Robinson, D., Koren, R., Agar, G., and Halperin, N. (2001). Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin.Exp.Rheumatol. 19: 265–270
   PubMed Web of Science ®Google Scholar
• Pendleton, A., Arden, N., Dougados, M., Doherty, M., Bannwarth, B., Bijlsma, J. W., Cluzeau, F., Cooper, C., Dieppe, P. A., Gunther, K. P., Hauselmann, H. J., Herrero-Beaumont, G., Kaklamanis, P. M., Leeb, B., Lequesne, M., Lohmander, S., Mazieres, B., Mola, E. M., Pavelka, K., Semi, U., Swoboda, B., Verbruggen, A. A., Weseloh, G., and Zimmermann-Gorska, I. (2000). EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Stand-ing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann. Rheum.Dis. 59: 936–944
   Google Scholar
• Chevalier, X, Conrozier T, Bertin, P, Bailleul, F, and Vignon, E (2000). Treatment of patients with symptomatic hip OA. A pilot study with intra-articular Hylan G-F 20 (synvisc). Arthritis Rheum. 43 (suppl.): 384
   Google Scholar
• Lanzotti, SB, Machado, MB, Nascimento, RA, Souza, SAA, Araujo-Junior, JC, and Torres, VNM (2000). Intra articular sodium hyaluronate in unilateral coxofemural osteoarthritis treatment. Ar-thritis Rheum. 43 (suppl): 336
   Google Scholar
• Migliore, A., Martin, L. S., Alimonti, A., Valente, C., and Tormenta, S. (2003). Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis.Cartilage. 11: 305–306
   PubMed Web of Science ®Google Scholar
• Migliore, A., Tormenta, S., Martin, L. S., Valente, C., Massafra, U., Granata, M., and Alimonti, A. (2005). Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin.Rheumatol. 24: 285–289
   PubMed Web of Science ®Google Scholar
• Migliore, A., Tormenta, S., Valente, C., Massafra, U., Martin Martin, L. S., Carmenini, E., Ber-nardini, A., and Alimonti, A. (2005). [Intra-articular treatment with Hylan G-F 20 under ultra-sound guidance in hip osteoarthritis. Clinical results after 12 months follow-up]. Reumatismo. 57: 36–43
   Google Scholar
• Migliore, A., Tormenta, S., Massafra, U., Carloni, E., Padalino, C., Iannessi, F., Alimonti, A., Martin, L. S., and Granata, M. (2005). Repeated ultrasound-guided intra-articular injections of 40 mg of Hyalgan may be useful in symptomatic relief of hip osteoarthritis. Osteoarthritis.Cartilage. 13: 1126–1127
   PubMed Web of Science ®Google Scholar
• Migliore, A., Tormenta, S., Martin Martin, L. S., Iannessi, F., Massafra, U., Carloni, E., Monno, D., Alimonti, A., and Granata, M. (2006). The symptomatic effects of intra-articular administra-tion of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin.Rheu-matol. 25: 389–393
   PubMed Web of Science ®Google Scholar
• Migliore, A., Tormenta, S., Massafra, U., Martin Martin, L. S., Carloni, E., Padalino, C., Alimonti, A., and Granata, M. (2006). 18-month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis. Reumatismo. 58: 39–49
   PubMedGoogle Scholar
• Van Den Bekerom, M. P., Mylle, G., Rys, B., and Mulier, M. (2006). Viscosupplementation in symptomatic severe hip osteoarthritis: a review of the literature and report on 60 patients. Acta Orthop.Belg. 72: 560–568
   PubMedGoogle Scholar
• Van Den Bekerom, M. P., Rys, B., and Mulier, M. (2008). Viscosupplementation in the hip: evalu-ation of hyaluronic acid formulations. Arch.Orthop.Trauma Surg. 128 (3): 275–280
   PubMed Web of Science ®Google Scholar
• Fletcher, B and Sackett, DL (1979). Canadian task force on the periodic health examination: the Periodic Health Examination. CMAJ 121: 1193–1254
   PubMedGoogle Scholar
• Laurent T.C. (2007). Hyaluronan Research in Uppsala. Upsala J Med Sci 112: 123–142
   PubMed Web of Science ®Google Scholar
• O'Regan, M., Martini, I., Crescenzi, F., De Luca, C., and Lansing, M. (1994). Molecular mecha-nisms and genetics of hyaluronan biosynthesis. Int.J.Biol.Macromol. 16: 283–286
   PubMed Web of Science ®Google Scholar
• Van Den Bekerom, M. P., Lamme, B., Sermon, A., and Mulier, M. (2007). What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature. Arch.Orthop.Trauma Surg. [Epub ahead of print; DOI 10.1007/s00402-007-0447-z]
   Google Scholar
• Kikuchi, T., Yamada, H., and Fujikawa, K. (2001). Effects of high molecular weight hyaluro-nan on the distribution and movement of proteoglycan around chondrocytes cultured in alginate beads. Osteoarthritis.Cartilage. 9: 351–356
   PubMed Web of Science ®Google Scholar
• Vad, V. B., Sakalkale, D., Sculco, T. P., and Wickiewicz, T. L. (2003). Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch.Phys.Med.Rehabil. 84: 1224–1226
   PubMed Web of Science ®Google Scholar
• Han, F., Ishiguro, N., Ito, T., Sakai, T., and Iwata, H. (1999). Effects of sodium hyaluronate on experimental osteoarthritis in rabbit knee joints. Nagoya J.Med.Sci. 62: 115–126
   PubMedGoogle Scholar
• Takahashi, K., Goomer, R. S., Harwood, F., Kubo, T., Hirasawa, Y, and Amiel, D. (1999). The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin- lbeta(IL- lbeta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of os-teoarthritis. Osteoarthritis.Cartilage. 7: 182–190
   PubMed Web of Science ®Google Scholar
• Goto, H., Onodera, T., Hirano, H., and Shimamura, T. (1999). Hyaluronic acid suppresses the reduction of alpha2(VI) collagen gene expression caused by interleukin-lbeta in cultured rabbit articular chondrocytes. Tohoku J.Exp.Med. 187: 1–13
   PubMed Web of Science ®Google Scholar
• Homandberg, G. A., Hui, F., Wen, C., Kuettner, K. E., and Williams, J. M. (1997). Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: I. In vitro. Osteoarthritis. Cartilage. 5: 309–319
   PubMedGoogle Scholar
• Williams, J. M., Plaza, V., Hui, F., Wen, C., Kuettner, K. E., and Homandberg, G. A. (1997). Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: II. In vivo. Osteoarthritis.Cartilage. 5: 235–240
   PubMedGoogle Scholar
• Bagga, H., Burkhardt, D., Sambrook, P., and March, L. (2006). Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J.Rheumatol. 33: 946–950
   PubMed Web of Science ®Google Scholar
• Ghosh, P. and Guidolin, D. (2002). Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin.Arthritis Rheum. 32: 10–37
   Google Scholar
• Aihara, S., Murakami, N., Ishii, R., Kariya, K., Azuma, Y, Hamada, K., Umemoto, J., and Maeda, S. (1992). Effects of sodium hyaluronate on the nociceptive response of rats with experimentally induced arthritis. Nippon Yakurigaku Zasshi 100: 359–365
   PubMed Web of Science ®Google Scholar
• Forrester, J. V. and Balazs, E. A. (1980). Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 40: 435–446
   PubMed Web of Science ®Google Scholar
• Berg, P. and Olsson, U. (2004). Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin.Exp.Rheumatol. 22: 300–306
   PubMed Web of Science ®Google Scholar
• Larsen, N. E., Leshchiner, E. A., Parent, E. G., Hendrikson-Aho, J., Balazs, E. A., and Hilal, S. K. (1991). Hylan gel composition for percutaneous embolization. J.Biomed.Mater.Res. 25: 699–710
   Google Scholar
• Weiss, C. and Band, P. (1995). Musculoskeletal applications of hyaluronan and hylan. Potential uses in the foot and ankle. Clin.Podiatr.Med.Surg. 12: 497–517
   PubMedGoogle Scholar
• Leopold, S. S., Battista, V., and Oliverio, J. A. (2001). Safety and efficacy of intraarticular hip injection using anatomic landmarks. Clin.Orthop.Relat Res. 192–197
   PubMed Web of Science ®Google Scholar
• Pourbagher, M. A., Ozalay, M., and Pourbagher, A. (2005). Accuracy and outcome of sono-graphically guided intra-articular sodium hyaluronate injections in patients with osteoarthritis of the hip. J.Ultrasound Med. 24: 1391–1395
   PubMed Web of Science ®Google Scholar
• Conrozier, T., Bertin, P., Mathieu, P., Charlot, J., Bailleul, F., Treves, R., Vignon, E., and Cheva-lier, X. (2003). Intra-articular injections of hylan G-F 20 in patients with symptomatic hip oste-oarthritis: an open-label, multicentre, pilot study. Clin.Exp.Rheumatol. 21: 605–610
   PubMed Web of Science ®Google Scholar
• Caglar-Yagci, H., Unsal, S., Yagci, I., Dulgeroglu, D., and Ozel, S. (2005). Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. Rheumatol.Int. 25: 341–344
   PubMed Web of Science ®Google Scholar
• Qvistgaard, E., Christensen, R., Torp-Pedersen, S., and Bliddal, H. (2006). Intra-articular treat-ment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis.Cartilage. 14: 163–170
   PubMed Web of Science ®Google Scholar
• Migliore, A., Tormenta, S., Martin Martin, L. S., Valente, C., Massafra, U., Latini, A., and Ali-monti, A. (2004). [Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip]. Reumatismo. 56: 104–109
   Google Scholar
• Gaston, M. S., Tiemessen, C. H., and Philips, J. E. (2007). Intra-articular hip viscosupplementa-tion with synthetic hyaluronic acid for osteoarthritis: efficacy, safety and relation to pre-injection radiographs. Arch.Orthop.Trauma Surg. 127: 899–903
   PubMed Web of Science ®Google Scholar
• Tikiz, C., Unlu, Z., Sener, A., Efe, M., and Tuzun, C. (2005). Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin. Rheumatol. 24: 244–250
   PubMed Web of Science ®Google Scholar
• Brocq, 0., Tran, G., Breuil, V, Grisot, C., Flory, P., and Euller-Ziegler, L. (2002). Hip osteoarthri-tis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 69: 388–391
   Google Scholar
• Kellgren, J. H. and Lawrence, J. S. (1957). Radiological assessment of osteo-arthrosis. Ann. Rheum.Dis. 16: 494–502
   PubMed Web of Science ®Google Scholar
• de Nies, F. and Fidler, M. W. (1997). Visual analog scale for the assessment of total hip arthro-plasty. J.Arthroplasty 12: 416–419
   PubMed Web of Science ®Google Scholar
• Bellamy, N., Buchanan, W. W., Goldsmith, C. H., Campbell, J., and Stitt, L. W. (1988). Valida-tion study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J.Rheumatol. 15: 1833–1840
   PubMed Web of Science ®Google Scholar
• Lequesne, M. G. (1997). The algofunctional indices for hip and knee osteoarthritis. J.Rheumatol. 24: 779–781
   PubMed Web of Science ®Google Scholar
• Conrozier, T., Bertin, P., Bailleul, F., Mathieu, P., Charlot, J., Vignon, E., Treves, R., and Cheva-lier, X. (2006). Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study. Joint Bone Spine 73: 705–709
   PubMed Web of Science ®Google Scholar
• Chazerain, P., Rolland, D., Cordonnier, C., and Ziza, J. M. (1999). Septic hip arthritis after mul-tiple injections into the joint of hyaluronate and glucocorticoid. Rev.Rhum.Engl.Ed 66: 436
   PubMedGoogle Scholar
• Egsmose, C., Lund, B., and Bach, Andersen R. (1984). Hip joint distension in osteoarthrosis. A triple-blind controlled study comparing the effect of intra-articular indoprofen with placebo. Scand.J.Rheumatol. 13: 238–242
   Google Scholar
• Kirwan, J. (2001). Is there a place for intra-articular hyaluronate in osteoarthritis of the knee? Knee. 8: 93–101
   Google Scholar
• Ravaud, P., Moulinier, L., Giraudeau, B., Ayral, X., Guerin, C., Noel, E., Thomas, P., Fautrel, B., Mazieres, B., and Dougados, M. (1999). Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum. 42: 475–482
   PubMed Web of Science ®Google Scholar